<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33308184</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide.</ArticleTitle><Pagination><StartPage>446</StartPage><MedlinePgn>446</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">446</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-020-02004-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Personalized ENCALS survival prediction model reliably estimates the personalized prognosis of patients with amyotrophic lateral sclerosis. Concerns were raised on discussing personalized prognosis without causing anxiety and destroying hope. Tailoring communication to patient readiness and patient needs mediates the impact of prognostic disclosure. We developed a communication guide to support physicians in discussing personalized prognosis tailored to individual needs and preferences of people with ALS and their families.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multidisciplinary working group of neurologists, rehabilitation physicians, and healthcare researchers A) identified relevant topics for guidance, B) conducted a systematic review on needs of patients regarding prognostic discussion in life-limiting disease, C) drafted recommendations based on evidence and expert opinion, and refined and finalized these recommendations in consensus rounds, based on feedback of an expert advisory panel (patients, family member, ethicist, and spiritual counsellor).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A) Topics identified for guidance were 1) filling in the ENCALS survival model, and interpreting outcomes and uncertainty, and 2) tailoring discussion to individual needs and preferences of patients (information needs, role and needs of family, severe cognitive impairment or frontotemporal dementia, and non-western patients). B) 17 studies were included in the systematic review. C) Consensus procedures on drafted recommendations focused on selection of outcomes, uncertainty about estimated survival, culturally sensitive communication, and lack of decisional capacity. Recommendations for discussing the prognosis include the following: discuss prognosis based on the prognostic groups and their median survival, or, if more precise information is desired, on the interquartile range of the survival probability. Investigate needs and preferences of the patients and their families for prognostic disclosure, regardless of cultural background. If the patient does not want to know their prognosis, with patient permission discuss the prognosis with their family. If the patient is judged to lack decisional capacity, ask the family if they want to discuss the prognosis. Tailor prognostic disclosure step by step, discuss it in terms of time range, and emphasize uncertainty of individual survival time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This communication guide supports physicians in tailoring discussion of personalized prognosis to the individual needs and preferences of people with ALS and their families.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Eenennaam</LastName><ForeName>Remko M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science &amp; Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruithof</LastName><ForeName>Willeke J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science &amp; Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruitwagen-van Reenen</LastName><ForeName>Esther T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science &amp; Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westeneng</LastName><ForeName>Henk-Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser-Meily</LastName><ForeName>Johanna M A</ForeName><Initials>JMA</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science &amp; Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beelen</LastName><ForeName>Anita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1269-0710</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science &amp; Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, the Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016-51</GrantID><Agency>ALS stichting Nederland (Netherlands ALS foundation)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010817" MajorTopicYN="Y">Physician-Patient Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014342" MajorTopicYN="Y">Truth Disclosure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Communication guide</Keyword><Keyword MajorTopicYN="N">Personalized prognosis</Keyword><Keyword MajorTopicYN="N">Physician-patient communication</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Truth disclosure</Keyword></KeywordList><CoiStatement>There are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33308184</ArticleId><ArticleId IdType="pmc">PMC7734773</ArticleId><ArticleId IdType="doi">10.1186/s12883-020-02004-8</ArticleId><ArticleId IdType="pii">10.1186/s12883-020-02004-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio GD, Sloan R, Pongratz DE. Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci. 1998;160(SUPPL. 1):S127&#x2013;S133. doi: 10.1016/S0022-510X(98)00211-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00211-1</ArticleId><ArticleId IdType="pubmed">9851662</ArticleId></ArticleIdList></Reference><Reference><Citation>Holloway RG, Gramling R, Kelly AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013;80:764&#x2013;772. doi: 10.1212/WNL.0b013e318282509c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318282509c</ArticleId><ArticleId IdType="pmc">PMC3589298</ArticleId><ArticleId IdType="pubmed">23420894</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): experiences of people with ALS/MND and family carers - a qualitative study. Amyotroph Lateral Scler. 2011;12:97&#x2013;104. doi: 10.3109/17482968.2010.546414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.546414</ArticleId><ArticleId IdType="pubmed">21208037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H. What if you knew the prognosis of your patients with ALS? Lancet Neurol. 2018;17:386&#x2013;388. doi: 10.1016/S1474-4422(18)30111-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30111-X</ArticleId><ArticleId IdType="pubmed">29598921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S, et al. Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med. 2007;21:507&#x2013;517. doi: 10.1177/0269216307080823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216307080823</ArticleId><ArticleId IdType="pubmed">17846091</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzinger AC, Zhang B, Schrag D, Prigerson HG. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J Clin Oncol. 2015;33:3809&#x2013;3816. doi: 10.1200/JCO.2015.61.9239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2015.61.9239</ArticleId><ArticleId IdType="pmc">PMC4737862</ArticleId><ArticleId IdType="pubmed">26438121</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield PE, Butow PN, Thompson JF, Tattersall MHN, Beeney LJ, Dunn SM. Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol. 2003;14:48&#x2013;56. doi: 10.1093/annonc/mdg010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdg010</ArticleId><ArticleId IdType="pubmed">12488292</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton JM, Butow PN, Arnold RM, Tattersall MHNN. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005;103:1965&#x2013;1975. doi: 10.1002/cncr.21011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.21011</ArticleId><ArticleId IdType="pubmed">15789360</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulourides Kogan A, Penido M, Enguidanos S. Does disclosure of terminal prognosis mean losing Hope? Insights from exploring patient perspectives on their experience of palliative care consultations. J Palliat Med. 2015;18:1019&#x2013;1025. doi: 10.1089/jpm.2015.0038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2015.0038</ArticleId><ArticleId IdType="pubmed">26288098</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenton JJ, Duberstein PR, Kravitz RL, Xing G, Tancredi DJ, Fiscella K, et al. Impact of prognostic discussions on the patient-physician relationship: prospective cohort study. J Clin Oncol. 2018;36:225&#x2013;230. doi: 10.1200/JCO.2017.75.6288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2017.75.6288</ArticleId><ArticleId IdType="pmc">PMC5773842</ArticleId><ArticleId IdType="pubmed">29148892</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Allan DE, Rocker G, Dodek P, Pichora D, Gafni A, et al. Discussing prognosis with patients and their families near the end of life: impact on satisfaction with end-of-life care. Open Med. 2009;3:e101&#x2013;e110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2765767</ArticleId><ArticleId IdType="pubmed">19946391</ArticleId></ArticleIdList></Reference><Reference><Citation>Butow P, Dowsett S, Hagerty R, Tattersall M. Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer. 2002;10:161&#x2013;168. doi: 10.1007/s005200100290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s005200100290</ArticleId><ArticleId IdType="pubmed">11862506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. Bmj. 2004;328:1343. doi: 10.1136/bmj.38103.423576.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38103.423576.55</ArticleId><ArticleId IdType="pmc">PMC420285</ArticleId><ArticleId IdType="pubmed">15151964</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak A, Butow PN, Davidson PM, Bellemore FA, Tattersall MHN, Clayton JM, et al. Patient perspectives regarding communication about prognosis and end-of-life issues: how can it be optimised? Patient Educ Couns. 2013;90:307&#x2013;314. doi: 10.1016/j.pec.2011.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2011.08.009</ArticleId><ArticleId IdType="pubmed">21920693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchison D, Butow P, Sze M, Aldridge L, Hui R, Vardy J, et al. Prognostic communication preferences of migrant patients and their relatives. Psychooncology. 2012;21:496&#x2013;504. doi: 10.1002/pon.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.1923</ArticleId><ArticleId IdType="pubmed">21351187</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis JR, Engelberg R, Young JP, Vig LK, Reinke LF, Wenrich MD, et al. An approach to understanding the interaction of Hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced Cancer. J Palliat Med. 2008;11:610&#x2013;620. doi: 10.1089/jpm.2007.0209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2007.0209</ArticleId><ArticleId IdType="pubmed">18454614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, et al. Communicating with realism and hope: incurable cancer patients&#x2019; views on the disclosure of prognosis. J Clin Oncol. 2005;23:1278&#x2013;1288. doi: 10.1200/JCO.2005.11.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2005.11.138</ArticleId><ArticleId IdType="pubmed">15718326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattellari M. When the treatment goal is not cure: are Cancer patients equipped to make informed decisions? J Clin Oncol. 2002;20:503&#x2013;513. doi: 10.1200/JCO.20.2.503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.20.2.503</ArticleId><ArticleId IdType="pubmed">11786580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Borasio GD. Breaking the news in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2004;5:195&#x2013;201. doi: 10.1080/14660820310017326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310017326</ArticleId><ArticleId IdType="pubmed">15799546</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoun SM, Breen LJ, Edis R, Henderson RD, Oliver D, Harris R, et al. Breaking the news of a diagnosis of motor neurone disease: a national survey of neurologists&#x2019; perspectives. J Neurol Sci. 2016;367:368&#x2013;374. doi: 10.1016/j.jns.2016.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.033</ArticleId><ArticleId IdType="pubmed">27423623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan R, Ugalde A, Sinclair C, Breen LJ. Developing a research agenda for adult palliative care: a modified Delphi study. J Palliat Med. 2019;22:480&#x2013;488. doi: 10.1089/jpm.2018.0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2018.0462</ArticleId><ArticleId IdType="pubmed">30461347</ArticleId></ArticleIdList></Reference><Reference><Citation>(NICE) NI for H and CE . Motor neurone disease: assessment and management. 2016.</Citation></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the quality standards Subcommittee of the American. Neurology. 2009;73:1227&#x2013;1233. doi: 10.1212/WNL.0b013e3181bc01a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc01a4</ArticleId><ArticleId IdType="pmc">PMC2764728</ArticleId><ArticleId IdType="pubmed">19822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver S, Harden A, Rees R, Shepherd J, Brunton G, Garcia J, et al. An emerging framework for including different types of evidence in systematic reviews for public policy. Evaluation. 2005;11:428&#x2013;446. doi: 10.1177/1356389005059383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1356389005059383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein RM, et al. Patient-clinician communication: American society of clinical oncology consensus guideline. J Clin Oncol. 2017;35:3618&#x2013;3632. doi: 10.1200/JCO.2017.75.2311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2017.75.2311</ArticleId><ArticleId IdType="pubmed">28892432</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton JM, Hancock KM, Butow PN, Tattersall MHN, Currow DC. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust. 2007;186:478. doi: 10.5694/j.1326-5377.2007.tb01100.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.2007.tb01100.x</ArticleId><ArticleId IdType="pubmed">17727340</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, et al. A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag. 2007;34:81&#x2013;93. doi: 10.1016/j.jpainsymman.2006.09.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2006.09.035</ArticleId><ArticleId IdType="pubmed">17531434</ArticleId></ArticleIdList></Reference><Reference><Citation>Innes S, Payne S. Advanced cancer patients&#x2019; prognostic information preferences: a review. Palliat Med. 2009;23:29&#x2013;39. doi: 10.1177/0269216308098799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216308098799</ArticleId><ArticleId IdType="pubmed">18952746</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton, Clayton JM, Clayton, Clayton JM, Hancock K, Parker S, et al. Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psychooncology. 2008;93:992&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">18022831</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodin G, Mackay JA, Zimmermann C, Mayer C, Howell D, Katz M, et al. Clinician-patient communication: a systematic review. Support Care Cancer. 2009;17:627&#x2013;644. doi: 10.1007/s00520-009-0601-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-009-0601-y</ArticleId><ArticleId IdType="pubmed">19259706</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton JM, Butow PN, Arnold RM, Tattersall MHN. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005;13:733&#x2013;742. doi: 10.1007/s00520-005-0789-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-005-0789-4</ArticleId><ArticleId IdType="pubmed">15761699</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton JM, Butow PN, Tattersall MHNN. When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manag. 2005;30:132&#x2013;144. doi: 10.1016/j.jpainsymman.2005.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2005.02.014</ArticleId><ArticleId IdType="pubmed">16125028</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrichsen M, Lindholm A, Milberg A. Experiences of truth disclosure in terminally ill cancer patients in palliative home care. Palliat Support Care. 2011;9:173&#x2013;180. doi: 10.1017/S1478951511000046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951511000046</ArticleId><ArticleId IdType="pubmed">24468485</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton JM, Butow PN, Tattersall MHN. The needs of terminally ill cancer patients versus those of caregivers for information regarding prognosis and end-of-life issues. Cancer. 2005;103:1957&#x2013;1964. doi: 10.1002/cncr.21010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.21010</ArticleId><ArticleId IdType="pubmed">15789363</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaff FM, Francke AL, Van Den Muijsenbergh MEETC, Van Der Geest S. &#x201c;Palliative care&#x201d;: a contradiction in terms? A qualitative study of cancer patients with a Turkish or Moroccan background, their relatives and care providers. BMC Palliat Care. 2010;9:19. doi: 10.1186/1472-684X-9-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-684X-9-19</ArticleId><ArticleId IdType="pmc">PMC2944252</ArticleId><ArticleId IdType="pubmed">20831777</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaff FM, Francke AL, Van den Muijsenbergh ME, Van der Geest S. Talking in triads: communication with Turkish and Moroccan immigrants in the palliative phase of cancer. J Clin Nurs. 2012;21:3143&#x2013;3152. doi: 10.1111/j.1365-2702.2012.04289.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2012.04289.x</ArticleId><ArticleId IdType="pubmed">23083389</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosterveld-Vlug MG, Francke AL, Pasman HRW, Onwuteaka-Philipsen BD. How should realism and hope be combined in physician-patient communication at the end of life? An online focus-group study among participants with and without a Muslim background. Palliat Support Care. 2017;15:359&#x2013;368. doi: 10.1017/S1478951516000833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951516000833</ArticleId><ArticleId IdType="pubmed">27819209</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Steen JT, Albers G, Licht-Strunk E, Muller MT, Ribbe MW. A validated risk score to estimate mortality risk in patients with dementia and pneumonia: barriers to clinical impact. Int Psychogeriatrics. 2011;23:31&#x2013;43. doi: 10.1017/S1041610210001079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610210001079</ArticleId><ArticleId IdType="pubmed">20653988</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt EG, Pieterse AH, van Duijn-Bakker N, Kroep JR, de HCJMJM H, EMAA S, et al. Breast cancer specialists&#x2019; views on and use of risk prediction models in clinical practice: A mixed methods approach. Acta Oncol (Madr) 2015;54:361&#x2013;367. doi: 10.3109/0284186X.2014.964810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0284186X.2014.964810</ArticleId><ArticleId IdType="pmc">PMC4445013</ArticleId><ArticleId IdType="pubmed">25307407</ArticleId></ArticleIdList></Reference><Reference><Citation>Longman T, Turner RM, King M, McCaffery KJ. The effects of communicating uncertainty in quantitative health risk estimates. Patient Educ Couns. 2012;89:252&#x2013;259. doi: 10.1016/j.pec.2012.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2012.07.010</ArticleId><ArticleId IdType="pubmed">22858415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely BE, Martin AJ, Tattersall MHN, Nowak AK, Goldstein D, Wilcken NRC, et al. The median informs the message: accuracy of individualized scenarios for survival time based on oncologists&#x2019; estimates. J Clin Oncol. 2013;31:3565&#x2013;3571. doi: 10.1200/JCO.2012.44.7821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2012.44.7821</ArticleId><ArticleId IdType="pubmed">24002504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, et al. Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Support Care Cancer. 2013;21:369&#x2013;376. doi: 10.1007/s00520-012-1526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-012-1526-4</ArticleId><ArticleId IdType="pubmed">22717918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients make sense of health statistics: toward an evidence-based society. Psychol Sci Public Interes. 2007;8:53&#x2013;96. doi: 10.1111/j.1539-6053.2008.00033.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1539-6053.2008.00033.x</ArticleId><ArticleId IdType="pubmed">26161749</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Retamero R, Cokely ET. Designing visual AIDS that promote risk literacy: a systematic review of Health Research and evidence-based design heuristics. Hum Factors. 2017;59:582&#x2013;627. doi: 10.1177/0018720817690634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0018720817690634</ArticleId><ArticleId IdType="pubmed">28192674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22:1721&#x2013;1730. doi: 10.1200/JCO.2004.04.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2004.04.095</ArticleId><ArticleId IdType="pubmed">15117995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagarde SM, Franssen SJ, Van Werven JR, Smets EMAA, Tran TCKK, Tilanus HW, et al. Patient preferences for the disclosure of prognosis after esophagectomy for cancer with curative intent. Ann Surg Oncol. 2008;15:3289&#x2013;3298. doi: 10.1245/s10434-008-0068-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-008-0068-y</ArticleId><ArticleId IdType="pubmed">18670823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, et al. Evidence-based risk communication. Ann Intern Med. 2014;161:270. doi: 10.7326/M14-0295.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0295</ArticleId><ArticleId IdType="pubmed">25133362</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeuwesen L, Harmsen JAM, Bernsen RMD, Bruijnzeels MA. Do Dutch doctors communicate differently with immigrant patients than with Dutch patients? Soc Sci Med. 2006;63:2407&#x2013;2417. doi: 10.1016/j.socscimed.2006.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2006.06.005</ArticleId><ArticleId IdType="pubmed">16928417</ArticleId></ArticleIdList></Reference><Reference><Citation>Schouten BC, Meeuwesen L, Harmsen HAMM. GPs&#x2019; interactional styles in consultations with dutch and ethnic minority patients. J Immigr Minor Health. 2009;11:468&#x2013;475. doi: 10.1007/s10903-008-9131-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10903-008-9131-9</ArticleId><ArticleId IdType="pmc">PMC2773123</ArticleId><ArticleId IdType="pubmed">18360790</ArticleId></ArticleIdList></Reference><Reference><Citation>Butow PN, Sze M, Eisenbruch M, Bell ML, Aldridge LJ, Abdo S, et al. Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Educ Couns. 2013;92:246&#x2013;252. doi: 10.1016/j.pec.2013.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2013.03.006</ArticleId><ArticleId IdType="pubmed">23541510</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternotte E, van Dulmen S, van der Lee N, Scherpbier AJJA, Scheele F. Factors influencing intercultural doctor-patient communication: a realist review. Patient Educ Couns. 2015;98:420&#x2013;445. doi: 10.1016/j.pec.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2014.11.018</ArticleId><ArticleId IdType="pubmed">25535014</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102&#x2013;108. doi: 10.1136/jnnp-2011-300188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Khin Khin E, Minor D, Holloway A, Pelleg A. Decisional capacity in amyotrophic lateral sclerosis. J Am Acad Psychiatry Law. 2015;43:210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">26071511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselt IK, Nijboer TCWW, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Front Degener. 2020;0:1&#x2013;13. doi: 10.1080/21678421.2020.1732424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1732424</ArticleId><ArticleId IdType="pubmed">32157912</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Turner MR, Hsieh S, Ahmed RM, Devenney E, Ramsey E, et al. Apathy is associated with poor prognosis in amyotrophic lateral sclerosis. Eur J Neurol. 2016;23:891&#x2013;897. doi: 10.1111/ene.12959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12959</ArticleId><ArticleId IdType="pubmed">26822417</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley G, Timonen V, Hardiman O. Exerting control and adapting to loss in amyotrophic lateral sclerosis. Soc Sci Med. 2014;101:113&#x2013;119. doi: 10.1016/j.socscimed.2013.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2013.11.003</ArticleId><ArticleId IdType="pubmed">24560231</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrow AB, Sood JR, Nolan MT, Terry PB, Clawson L, Kub J, et al. Decision-making in patients with advanced cancer compared with amyotrophic lateral sclerosis. J Med Ethics. 2008;34:664&#x2013;668. doi: 10.1136/jme.2007.022731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jme.2007.022731</ArticleId><ArticleId IdType="pmc">PMC2572766</ArticleId><ArticleId IdType="pubmed">18757636</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370&#x2013;e1380. doi: 10.1212/WNL.0000000000006317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006317</ArticleId><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaff FM, Francke AL, Van Den Muijsenbergh METC, Van Der Geest S. Understanding and improving communication and decision-making in palliative care for Turkish and Moroccan immigrants: a multiperspective study. Ethn Health. 2012;17:363&#x2013;384. doi: 10.1080/13557858.2011.645152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13557858.2011.645152</ArticleId><ArticleId IdType="pubmed">22229704</ArticleId></ArticleIdList></Reference><Reference><Citation>CBS . Annual Report on Integration 2018: Summary. 2018.</Citation></Reference><Reference><Citation>De Graeff A, Mistiaen P, de Graaff FM, Van den Muijsenbergh M, Galesloot CM, Lamkaddem M, et al. Handreiking Palliatieve zorg aan mensen met een niet-westerse achtergrond. Ned Tijdschr voor Palliat Zorg. 2012;12:4&#x2013;20.</Citation></Reference><Reference><Citation>ENCALS Survival Prediction Model. http://encalssurvivalmodel.org/. Accessed 3 June 2019.</Citation></Reference><Reference><Citation>ALS Center Netherlands. https://www.als-centrum.nl/. Accessed 3 June 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>